{"id":1397,"date":"2004-02-24T01:00:00","date_gmt":"2004-02-24T01:00:00","guid":{"rendered":"https:\/\/www.ebrofoods.es\/news\/puleva-biotech-raises-its-net-profit-57-3-in-2003-04-02\/"},"modified":"2017-11-03T12:57:54","modified_gmt":"2017-11-03T12:57:54","slug":"puleva-biotech-raises-its-net-profit-57-3-in-2003-04-02","status":"publish","type":"post","link":"https:\/\/www.ebrofoods.es\/en\/news\/puleva-biotech-raises-its-net-profit-57-3-in-2003-04-02\/","title":{"rendered":"Puleva Biotech raises its net profit 57.3% in 2003"},"content":{"rendered":"<p>&middot;\tIt recorded a turnover of 4.6 million euro, 26.4% up on 2003<\/p>\n<p><b>Granada \/ Madrid, 24 February 2004.<\/b> PULEVA BIOTECH chalked up a net profit of 1.9 million euro in 2003, 57.3% up on the profits posted in 2002. Its net turnover totalled 4.6 million euro, representing a year-on-year growth of 26.4%. <\/p>\n<p>PULEVA BIOTECH pushed ahead during 2003 with the provision of R+D+i services for other companies while taking great strides in its own research and development activities.<\/p>\n<p>Several new technologies were also implemented in PULEVA BIOTECH in 2003, including molecular evolution techniques for the production of proteins and other metabolites of nutritional interest, a genomic research platform to study the effects of different nutrients and foods on the expression of certain genes, and a metabolic unit to assess the effects of functional foods on humans.<\/p>\n<p>During 2003 the company began implementing a standardised R+D+i management system, in accordance with AENOR standard 166.002, official certification of which is expected to be obtained in 2004.<\/p>\n<p><u><b>Negotiation of collaboration agreements with multinationals<\/b><\/u><\/p>\n<p>Finally, the company embarked in 2003 on an ambitious commercial plan for the provision of R+D+i services and marketing of own products. Collaboration agreements are being negotiated with leading multinational enterprises, which PULEVA BIOTECH hopes to close this year.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Puleva Biotech recorded a turnover of 4.6 million euro.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[19],"tags":[],"class_list":["post-1397","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/www.ebrofoods.es\/en\/wp-json\/wp\/v2\/posts\/1397","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ebrofoods.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ebrofoods.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ebrofoods.es\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ebrofoods.es\/en\/wp-json\/wp\/v2\/comments?post=1397"}],"version-history":[{"count":0,"href":"https:\/\/www.ebrofoods.es\/en\/wp-json\/wp\/v2\/posts\/1397\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.ebrofoods.es\/en\/wp-json\/wp\/v2\/media?parent=1397"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ebrofoods.es\/en\/wp-json\/wp\/v2\/categories?post=1397"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ebrofoods.es\/en\/wp-json\/wp\/v2\/tags?post=1397"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}